urea has been researched along with azd 6244 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Almenara, JA; Bodie, WW; Chen, S; Dai, Y; Dent, P; Felthousen, J; Grant, S; Kramer, LB; Pei, XY; Takabatake, Y; Youssefian, LE | 1 |
2 other study(ies) available for urea and azd 6244
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2.
Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Checkpoint Kinase 1; DNA Damage; G1 Phase; Humans; Interleukin-6; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Multiple Myeloma; Protein Kinase Inhibitors; Protein Kinases; Resting Phase, Cell Cycle; Syndecan-1; Thiophenes; Urea | 2011 |